Detalhe da pesquisa
1.
A randomised phase II study of extended pleurectomy/decortication (e-PD) preceded or followed by chemotherapy in patients (pts) with early-stage pleural mesothelioma (PM): EORTC 1205.
Eur Respir J
; 2024 Jun 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38843916
2.
Comparing modeling strategies combining changes in multiple serum tumor biomarkers for early prediction of immunotherapy non-response in non-small cell lung cancer.
Tumour Biol
; 46(s1): S269-S281, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-37545289
3.
Prevalence and Predictors of Physician-Patient Discordance in Prognostic Perceptions in Advanced Cancer.
Oncologist
; 28(8): e653-e668, 2023 08 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37159001
4.
Osimertinib with Chemotherapy in EGFR-Mutated NSCLC.
N Engl J Med
; 390(5): 478, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38294983
5.
Characteristics of patients with advanced cancer preferring not to know prognosis: a multicenter survey study.
BMC Cancer
; 22(1): 941, 2022 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36050628
6.
Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden.
N Engl J Med
; 378(22): 2093-2104, 2018 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-29658845
7.
The psychosocial impact of living with mesothelioma: Experiences and needs of patients and their carers regarding supportive care.
Eur J Cancer Care (Engl)
; 30(6): e13498, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34339095
8.
Experiences of healthcare professionals with support for mesothelioma patients and their relatives: Identified gaps and improvements for care.
Eur J Cancer Care (Engl)
; 30(6): e13509, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34498770
9.
Optimal Therapy of Advanced Stage Mesothelioma.
Curr Treat Options Oncol
; 18(8): 48, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28681207
10.
A proteomics-based approach identifies secreted protein acidic and rich in cysteine as a prognostic biomarker in malignant pleural mesothelioma.
Br J Cancer
; 114(5): 524-31, 2016 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26889976
11.
Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy.
Invest New Drugs
; 33(1): 201-14, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25344453
12.
(18)F-fluorodeoxyglucose positron emission tomography versus computed tomography in predicting histopathological response to epidermal growth factor receptor-tyrosine kinase inhibitor treatment in resectable non-small cell lung cancer.
Ann Surg Oncol
; 21(9): 2831-7, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24845729
13.
Malignant pleural effusions: will PROMISE make its name true?
Lancet Oncol
; 19(7): 853-855, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29908988
14.
The use of indwelling pleural catheters for the management of malignant pleural effusion--direct costs in a Dutch hospital.
Respiration
; 86(3): 224-8, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23887083
15.
Broadening the scope for three-dimensional printed airway stents.
ERJ Open Res
; 9(2)2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36891070
16.
Identification of protein biomarkers for prediction of response to platinum-based treatment regimens in patients with non-small cell lung cancer.
Mol Oncol
; 2023 Nov 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38010703
17.
Prognostic Value of Nivolumab Clearance in Non-Small Cell Lung Cancer Patients for Survival Early in Treatment.
Clin Pharmacokinet
; 62(12): 1749-1754, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37856040
18.
Germline polymorphisms in patients with advanced nonsmall cell lung cancer receiving first-line platinum-gemcitabine chemotherapy: a prospective clinical study.
Cancer
; 118(9): 2466-75, 2012 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22031394
19.
Local treatment of pulmonary metastases: from open resection to minimally invasive approach? Less morbidity, comparable local control.
Surg Endosc
; 26(8): 2312-21, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22350235
20.
Modeling strategies to analyse longitudinal biomarker data: An illustration on predicting immunotherapy non-response in non-small cell lung cancer.
Heliyon
; 8(10): e10932, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36254284